"10.1371_journal.pone.0090337","plos one","2014-02-27T00:00:00Z","Bianca C Bernardo; Xiao-Ming Gao; Yow Keat Tham; Helen Kiriazis; Catherine E Winbanks; Jenny Y Y Ooi; Esther J H Boey; Susanna Obad; Sakari Kauppinen; Paul Gregorevic; Xiao-Jun Du; Ruby C Y Lin; Julie R McMullen","Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia; Santaris Pharma, Horsholm, Denmark; Department of Haematology, Aalborg University Hospital, Copenhagen, Denmark; Ramaciotti Centre for Genomics, School of Biotechnology & Biomolecular Sciences, University of New South Wales, Sydney, New South Wales, Australia; Departments of Medicine Monash University, Clayton, Victoria, Australia; Departments of Physiology, Monash University, Clayton, Victoria, Australia","Conceived and designed the experiments: BCB SO SK RCYL JRM. Performed the experiments: BCB XMG YKT HK CEW JYYO EJHB XJD JRM. Analyzed the data: BCB CEW JYYO YKT JRM. Contributed reagents/materials/analysis tools: SO SK PG. Wrote the paper: BCB JRM.","S.O. is an employee of Santaris Pharma A/S, a clinical stage biopharmaceutical company that develops RNA-based therapeutics. S.K. is a former employee of Santaris Pharma A/S and is now Professor at the Department of Haematology, Aalborg University Hospital. Depending on the field of use, LNA oligonucleotides can be obtained from Santaris Pharma A/S or Exiqon. This does not alter the authors adherence to all PLOS ONE policies on sharing data and materials.","2014","02","Bianca C Bernardo","BCB",13,TRUE,5,9,5,2,TRUE,TRUE,FALSE,0,NA,FALSE
